Peculiar features and tailored management of adult cancers occurring in pediatric age

References

• Thun MJ, DeLancey JO, Center MM et al. The global burden of cancer: priorities for prevention. Carcinogenesis31(1), 100–110 (2009).
   PubMed Web of Science ®Google Scholar
• Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. IARC Press, Lyon, France (2004).
   Google Scholar
• Conti EMS, Cercato MC, Gatta G et al. Childhood melanoma in Europe since 1978: a population-based survival study. Eur. J. Cancer37, 780–784 (2001).
   PubMedGoogle Scholar
• De Vries E, Steliarova-Foucher E, Spatz A et al. Skin cancer incidence and survival in European children and adolescents (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur. J. Cancer42(13), 2170–2182 (2006).
   PubMedGoogle Scholar
• Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the Surveillance, Epidemiology and End Results database. J. Clin. Oncol.23, 4753–4741 (2005).
   Google Scholar
• Pastore G, De Salvo GL, Bisogno G et al. Evaluating the access to pediatric cancer care centres of children and adolescents with rare tumors in Italy: the TREP project. Ped. Blood Cancer53(2), 152–155 (2009).
   PubMed Web of Science ®Google Scholar
• Milton GW, Shaw HM, Thompson JF, McCarthy WH. Cutaneous melanoma in childhood: incidence and prognosis. Australas. J. Dermatol.38, 44–48 (1997).
   PubMedGoogle Scholar
• Karlsson PM, Fredrikson M. Cutaneous malignant melanoma in children and adolescents in Sweden, 1993–2002: the increasing trend is broken. Int. J. Cancer121(2), 323–328 (2007).
   PubMed Web of Science ®Google Scholar
• Hayward NK. Genetics of melanoma predisposition. Oncogene22, 3053–3062 (2003).
   PubMed Web of Science ®Google Scholar
• Whiteman DC, Milligan A, Welch J et al. Germline CDKN2A mutations in childhood melanoma. J. Natl Cancer Inst.89, 1460 (1997).
   PubMedGoogle Scholar
• Danietti M, Ferrari A, Frigerio S et al. Cutaneous melanoma on childhood and adolescence shows frequent loss of INK4A and gain of KIT. J. Invest. Dermatol.129(7), 1759–1768 (2009).
   PubMedGoogle Scholar
• Uribe P, Wistuba II, Solar A et al. Comparative analysis of loss of heterozygosity and microsatellite instability in adult and pediatric melanoma. Am. J. Dermatopathol.27, 279–285 (2005).
   PubMedGoogle Scholar
• Easton DF, Eeles RA. Genome-wide association studies in cancer. Hum. Mol. Genet.17(R2), R109–R115 (2008).
   PubMed Web of Science ®Google Scholar
• Pappo AS. Melanoma in children and adolescents. Eur. J. Cancer39, 2651–2661 (2003).
   PubMed Web of Science ®Google Scholar
• Lange JR, Palis BE, Chang DC et al. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J. Clin. Oncol.25(11), 1363–1368 (2007).
   PubMed Web of Science ®Google Scholar
• Livestro DP, Kaine EM, Michaelson JS et al. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer110(3), 614–624 (2007).
   PubMed Web of Science ®Google Scholar
• Ceballos PI, Ruiz-Maldonado R, Mihm MC Jr. Melanoma in children. N. Engl. J. Med.332, 656–662 (1995).
   PubMed Web of Science ®Google Scholar
• Mones JM, Ackerman AB. Melanomas in prepubescent children. Review comprehensively, critique historically, criteria diagnostically, and course biologically. Am. J. Dermatopathol.25, 223–238 (2003).
   PubMed Web of Science ®Google Scholar
• Sander B, Karlsson P, Rosdahl I et al. Cutaneous malignant melanoma in Swedish children and teenagers 1973–1992: a clinico-pathological study of 130 cases. Int. J. Cancer80, 646–651 (1999).
   PubMed Web of Science ®Google Scholar
• Ferrari A, Bono A, Baldi M et al. Does melanoma behave better in younger children than in adults? A retrospective study on 33 cases of childhood melanoma from a single institution. Pediatrics115(3), 649–654 (2005).
   PubMed Web of Science ®Google Scholar
• Saenz NC, Saenz-Badillos J, Busam K et al. Childhood melanoma survival. Cancer85, 750–754 (1999).
   PubMedGoogle Scholar
• Spatz A, Ruiter D, Hardmeier T et al. Melanoma in childhood: an EORTC–MCG multicenter study on the clinicopathological aspects. Int. J. Cancer4, 317–324 (1996).
   Google Scholar
• Berk DR, LaBuz E, Dadras SS et al. Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults – the Stanford experience 1995–2008. Pediatr. Dermatol.27(3), 244–254 (2010).
   PubMedGoogle Scholar
• Cerroni L, Barnhill R, Elder D et al. Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. Am. J. Surg. Pathol.34(3), 314–326 (2010).
   PubMedGoogle Scholar
• Bauer J, Bastian BC. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol. Ther.9(1), 40–49 (2006).
   Google Scholar
• Richardson SK, Tannous ZS, Mihm MC. Congenital and infantile melanoma: review of the literature and report of an uncommon variant, pigment-synthesizing melanoma. J. Am. Acad. Dermatol.47, 77–90 (2002).
   PubMedGoogle Scholar
• Butter A, Hui T, Chapdelaine J et al. Melanoma in children and the use of sentinel lymph node biopsy. J. Pediatr. Surg.40(5), 797–800 (2005).
   PubMedGoogle Scholar
• Roaten JB, Partrick DA, Bensard D et al. Survival in sentinel lymph node-positive pediatric melanoma. J. Pediatr. Surg.40(6), 988–992 (2005).
   PubMedGoogle Scholar
• Chao MM, Schwartz JL, Wechsler DS et al. High-risk surgically resected pediatric melanoma and adjuvant interferon therapy. Pediatr. Blood Cancer44(5), 441–448 (2005).
   PubMed Web of Science ®Google Scholar
• Navid F, Furman WL, Fleming M et al. The feasibility of adjuvant interferon α-2b in children with high-risk melanoma. Cancer103(4), 780–787 (2005).
   PubMed Web of Science ®Google Scholar
• Shah NC, Gerstle JT, Stuart M et al. Use of sentinel lymph node biopsy and high-dose interferon in pediatric patients with high-risk melanoma: the Hospital for Sick Children experience. J. Pediatr. Hematol. Oncol.28(8), 496–500 (2006).
   PubMed Web of Science ®Google Scholar
• Rao BN, Pratt CB, Fleming ID et al. Colon carcinoma in children and adolescents. A review of 30 cases. Cancer55(6), 1322–1326 (1985).
   PubMed Web of Science ®Google Scholar
• LaQuaglia MP, Heller G, Filippa DA et al. Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma. J. Pediatr. Surg.27(8), 1085–1089 (1992).
   PubMedGoogle Scholar
• Pratt CB, Rao BN, Merchant TE et al. Treatment of colorectal carcinoma in adolescents and young adults with surgery, 5-fluorouracil/leucovorin/interferon-α 2a and radiation therapy. Med. Pediatr. Oncol.32(6), 459–460 (1999).
   PubMedGoogle Scholar
• Radhakrishnan CN, Bruce J. Colorectal cancers in children without any predisposing factors. A report of eight cases and review of the literature. Eur. J. Pediatr. Surg.13(1), 66–68 (2003).
   PubMedGoogle Scholar
• Durno C, Aronson M, Bapat B et al. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut54(8), 1146–1150 (2005).
   PubMed Web of Science ®Google Scholar
• Chantada GL, Perelli VB, Lombardi MG et al. Colorectal carcinoma in children, adolescents, and young adults. J. Pediatr. Hematol. Oncol.27(1), 39–41 (2005).
   PubMedGoogle Scholar
• Kravarusic D, Feigin E, Dlugy E et al. Colorectal carcinoma in childhood: a retrospective multicenter study. J. Pediatr. Gastroenterol. Nutr.44(2), 209–211 (2007).
   PubMedGoogle Scholar
• Ferrari A, Rognone A, Casanova M et al. Colorectal carcinoma in children and adolescents: the experience of the Istituto Nazionale Tumori of Milan, Italy. Pediatr. Blood Cancer50(3), 588–593 (2008).
   PubMedGoogle Scholar
• Hill DA, Furman WL, Billups CA et al. Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. J. Clin. Oncol.25(36), 5808–5814 (2007).
   PubMedGoogle Scholar
• Saab R, Furman WL. Epidemiology and management options for colorectal cancer in children. Pediatr. Drugs10(3), 177–192 (2008).
   PubMedGoogle Scholar
• Sultan I, Rodriguez-Galindo C, El-Tani H et al. Colorectal cancer in children and adolescents: a population based study of 159 cases with comparison to adult cases. Cancer116(3), 758–765 (2010).
   PubMed Web of Science ®Google Scholar
• Kim HC, Kim CN, Yu CS et al. Methylation of the hMLH1 and hMSH2 promoter in early-onset sporadic colorectal carcinomas with microsatellite instability. Int. J. Colorectal Dis.18(3), 196–202 (2003).
   PubMedGoogle Scholar
• Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science278(5340), 1043–1050 (1997).
   PubMed Web of Science ®Google Scholar
• Losi L, Di Gregorio C, Pedroni M et al. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes. Am. J. Gastroenterol.100(10), 2280–2287 (2005).
   PubMed Web of Science ®Google Scholar
• Simons AJ, Ker R, Groshen S et al. Variations in treatment of rectal cancer: the influence of hospital type and caseload. Dis. Colon Rectum40, 641–646 (1997).
   PubMedGoogle Scholar
• Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann. Surg.227, 157–167 (1998).
   PubMed Web of Science ®Google Scholar
• Chang MH. Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization. Liver Int.23, 309–314 (2003).
   PubMedGoogle Scholar
• Czauderna P. Adult type vs. childhood hepatocellular carcinoma – are they the same or different lesions? Biology, natural history, prognosis and treatment. Med. Pediatr. Oncol.39, 519–523 (2002).
   PubMedGoogle Scholar
• Prokurat A Kluge P, Kościesza A et al. Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing β-catenin. Med. Pediatr. Oncol.39, 510–518 (2000).
   Google Scholar
• Mazzaferro V, Regallia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N. Engl. J. Med.334, 693–699 (1996).
   PubMed Web of Science ®Google Scholar
• Haberal M, Emiroglu R, Karakayali H et al. Expanded criteria for hepatocellular carcinoma and liver transplantation. Int. Surg.92, 110–115 (2007).
   PubMedGoogle Scholar
• Tagge EP, Tagge DU, Reyes J et al. Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J. Pediatr. Surg.27, 292–297 (1992).
   PubMedGoogle Scholar
• Iwatsuki S, Starzl TE, Sheahan DG et al. Hepatic resection vs. transplantation for hepatocellular carcinoma. Ann. Surg.214, 221–229 (1991).
   PubMed Web of Science ®Google Scholar
• Reyes JD, Carr B, Dvorchik I et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J. Pediatr.136, 795–804 (2000).
   PubMedGoogle Scholar
• Malogolowkin MH, Katzenstein H, Krailo MD et al. Feasibility and toxicity of chemoembolization for children with liver tumors. J. Clin. Oncol.18, 1279–1284 (2000).
   PubMedGoogle Scholar
• Llovet JM, Ricci S, Mazzaferro V et al. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med.359, 378–390 (2008).
   PubMed Web of Science ®Google Scholar
• Katzenstein HM, Krailo MD, Malogolowkin MH et al. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children’s Cancer Group Intergroup Study. J. Clin. Oncol.20, 2789–2797 (2002).
   PubMedGoogle Scholar
• Czauderna P, Mackinlay G, Perilongo G et al. Hepatocellular carcinoma in children – results of the first prospective trial of the International Society of Pediatric Oncology (SIOP) – SIOPEL 1. J. Clin. Oncol.20, 2798–2804 (2002).
   PubMed Web of Science ®Google Scholar
• Perilongo G, Shafford E, Maibach R et al. Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Pediatric Oncology – SIOPEL 2. Eur. J. Cancer40, 411–421 (2004).
   PubMed Web of Science ®Google Scholar
• Collini P, Mattavelli F, Spinelli C, Massimino M. Treatment of sporadic nonmedullary thyroid carcinomas in pediatric age. Expert Rev. Anticancer Ther.7(1), 23–30 (2007).
   PubMed Web of Science ®Google Scholar
• LaQuaglia MP, Corbally MT, Heller G et al. Recurrence and morbidity in differentiated thyroid carcinoma in children. Surgery104, 1149–1156 (1988).
   PubMed Web of Science ®Google Scholar
• Massimino M, Collini P, Fagundes Leite S et al. Conservative surgical approach for thyroid and lymph-node involvement in papillary thyroid carcinoma of childhood and adolescence. Pediatr. Blood Cancer46, 307–313 (2006).
   PubMedGoogle Scholar
• Collini P, Massimino M, Fagundes Leite S, et al. Papillary thyroid carcinoma of childhood and adolescence: a 30-year experience at the Istituto Nazionale Tumori in Milan. Pediatr. Blood Cancer46, 300–306 (2006).
   PubMedGoogle Scholar
• Collini P, Mattavelli F, Pellegrinelli A et al. Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behaviour and prognosis. A clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am. J. Surg. Pathol.30(11), 1420–1426 (2006).
   PubMed Web of Science ®Google Scholar
• Cady B. Presidential address: beyond risk groups – a new look at differentiated thyroid cancer. Surgery124, 947–957 (1998).
   PubMedGoogle Scholar
• Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid12(8), 683–702 (2002).
   PubMedGoogle Scholar
• Rachmiel M, Charron M, Gupta A et al. Evidence-based review of treatment and follow up of pediatric patients with differentiated thyroid carcinoma. J. Pediatr. Endocrinol. Metab.19(12), 1377–1393 (2006).
   PubMedGoogle Scholar
• Bray F, Haugen M, Moger TA et al. Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol. Biomarkers Prev.17(9), 2356–2365 (2008).
   PubMedGoogle Scholar
• Ayan I, Kaytan E, Ayan N. Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol.4(1), 13–21 (2003).
   PubMed Web of Science ®Google Scholar
• Pathmanathan R, Prasad U, Sadler R et al. Clonal proliferations of cells infected with Epstein–Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med.333(11), 693–698 (1995).
   PubMed Web of Science ®Google Scholar
• Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev.15(10), 1765–1777 (2006).
   PubMed Web of Science ®Google Scholar
• Sultan I, Casanova M, Ferrari A et al. Differential features of nasopharyngeal carcinoma in children and adults: a SEER study. Pediatr. Blood Cancer55(2), 279–284 (2010).
   PubMed Web of Science ®Google Scholar
• Langendijk JA, Leemans CR, Buter J et al. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J. Clin. Oncol.22(22), 4604–4612 (2004).
   PubMed Web of Science ®Google Scholar
• Pao WJ, Hustu HO, Douglass EC et al. Pediatric nasopharyngeal carcinoma: long term follow-up of 29 patients. Int. J. Radiat. Oncol. Biol. Phys.17(2), 299–305 (1989).
   PubMedGoogle Scholar
• Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet365(9476), 2041–2054 (2005).
   PubMed Web of Science ®Google Scholar
• Chan SH, Ng WT, Kam KL et al. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Int. J. Radiat. Oncol. Biol. Phys.73(5), 1335–1342 (2009).
   PubMed Web of Science ®Google Scholar
• Chen MC, Feng IJ, Lu CH et al. The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979–2003). Ann. Oncol.19(6), 1180–1186 (2008).
   PubMed Web of Science ®Google Scholar
• Ulger S, Ulger Z, Yildiz F, Ozyar E. Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma. Med. Oncol.24(1), 91–94 (2007).
   PubMedGoogle Scholar
• Rodriguez-Galindo C, Wofford M, Castleberry RP et al. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Cancer103(4), 850–857 (2005).
   PubMed Web of Science ®Google Scholar
• Mertens R, Granzen B, Lassay L et al. Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a multicenter study (NPC-91-GPOH). Cancer104(5), 1083–1089 (2005).
   PubMed Web of Science ®Google Scholar
• Comoli P, De Palma R, Siena S et al. Adoptive transfer of allogeneic Epstein–Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma. Ann. Oncol.15(1), 113–117 (2004).
   PubMed Web of Science ®Google Scholar
• Straathof KC, Bollard CM, Popat U et al. Treatment of nasopharyngeal carcinoma with Epstein–Barr virus-specific T lymphocytes. Blood105(5), 1898–1904 (2005).
   PubMed Web of Science ®Google Scholar
• Laskar S, Bahl G, Muckaden M et al. Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.72(3), 728–736 (2008).
   PubMed Web of Science ®Google Scholar
• Varan A, Ozyar E, Corapçioğlu F et al. Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation cisplatin and docetaxel chemotherapy. Int. J. Radiat. Oncol. Biol. Phys.73(4), 1116–1120 (2009).
   PubMedGoogle Scholar
• Ng SH, Chan SC, Yen TC et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. Eur. J. Nucl. Med. Mol. Imaging36(1), 12–22 (2009).
   PubMedGoogle Scholar
• Ji MF, Wang DK, Yu YL et al. Sustained elevation of Epstein–Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br. J. Cancer96(4), 623–630 (2007).
   PubMedGoogle Scholar
• Guzzo M, Ferrari A, Marcon I et al. Salivary gland neoplasms in children: the experience of the Istituto Nazionale Tumori of Milan. Pediatr. Blood Cancer47(6), 806–810 (2006).
   PubMedGoogle Scholar
• Shikhani AH, Johns ME. Tumors of the major salivary glands in children. Head Neck Surg.10(4), 257–263 (1988).
   PubMedGoogle Scholar
• Sultan I, Rodriguez-Galindo C, Al-Sharabati S, Guzzo M, Casanova M, Ferrari A. Salivary gland carcinomas in children and adolescents: a population-based study, with comparison to adult cases. Head Neck (2010) (In press).
   PubMedGoogle Scholar
• Okcu MF, Hicks J, Merchant TE et al. Nonrhabdomyosarcomatous soft tissue sarcomas. In: Principles and Practice of Pediatric Oncology (5th Edition). Pizzo PA, Poplack DC (Eds). Lippincott Williams & Wilkins, PA, USA, 1033–1073 (2006).
   Google Scholar
• Ferrari A, Casanova M. New concepts for the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas. Expert Rev. Anticancer Ther.5(2), 307–318 (2005).
   PubMed Web of Science ®Google Scholar
• Ferrari A, Casanova M, Meazza C et al. Adult-type soft tissue sarcomas in pediatric age: experience at the Istituto Nazionale Tumori in Milan. J. Clin. Oncol.23, 4021–4030 (2005).
   PubMed Web of Science ®Google Scholar
• Ferrari A, Miceli R, Casanova M et al. Adult-type soft tissue sarcomas in paediatric age: a nomogram-based prognostic comparison with adult sarcoma. Eur. J. Cancer43(18), 2691–2697 (2007).
   PubMed Web of Science ®Google Scholar
• Ferrari A. Harmonizing adult and pediatric approaches to the treatment of soft tissue sarcoma. Expert Rev. Anticancer Ther.9(11), 1541–1543 (2009).
   PubMed Web of Science ®Google Scholar
• Sultan I, Rodriguez-Galindo C, Saab R et al. Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology and End Results Program, 1983 to 2005: an analysis of 1268 patients. Cancer115(15), 3537–3547 (2009).
   PubMed Web of Science ®Google Scholar
• Ferrari A, Gronchi A, Casanova M et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer101, 627–634 (2004).
   PubMed Web of Science ®Google Scholar
• Demetri GD, Benjamin RS, Blanke CD et al. NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumors (GIST) – update of the NCCN clinical practice guidelines. J. Natl Compr. Cancer Netw.5(2), S1–S29 (2007).
   PubMedGoogle Scholar
• Benesch M, Wardelmann E, Ferrari A et al. Gastrointestinal stromal tumors (GIST) in children and adolescents: a comprehensive review of the current literature. Ped. Blood Cancer53, 1171–1179 (2009).
   PubMed Web of Science ®Google Scholar
• Janeway KA, Liegl B, Harlow B et al. Pediatric KIT–wild-type and platelet-derived growth factor receptor α–wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors. Cancer Res.67, 9084–9088 (2007).
   PubMed Web of Science ®Google Scholar
• Pappo AS, Janeway KA. Pediatric gastrointestinal stromal tumors. Hematol. Oncol. Clin. North Am.23(1), 15–34, (2009).
   PubMedGoogle Scholar
• Kim SY, Janeway K, Pappo A. Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches. Curr. Opin. Oncol.22(4), 347–350 (2010).
   PubMed Web of Science ®Google Scholar
• Janeway KA, Zhu MJ, Barretina J et al. Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification. Int. J. Cancer DOI: 10.1002/ijc.25247 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Janeway KA, Albritton KH, Van Den Abbeele AD et al. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib. Pediatr. Blood Cancer52(7), 767–771 (2009).
   PubMed Web of Science ®Google Scholar
• Ferrari A, Bisogno G, De Salvo GL et al. The challenge of very rare tumours in childhood: the Italian TREP project. Eur. J. Cancer43, 654–659 (2007).
   PubMed Web of Science ®Google Scholar
• Michalkiewicz E, Sandrini R, Figueiredo B et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Paediatric Adrenocortical Tumor Registry. J. Clin. Oncol.22(5), 838–845 (2004).
   PubMedGoogle Scholar
• Priest JR, Messinger Y, Finkelstein MJ et al. Treatment modality vs outcome in Type I pleuropulmonary blastoma (PPB) – results from The PPB Registry. Pediatr. Blood Cancer44(6), 544 (2005) (Abstract).
   Google Scholar
• Ferrari A. The Challenge of Very Rare Pediatric Tumors: the Italian TREP Project. Educational Book, American Society of Clinical Oncology Annual Meeting, 620–624 (2009).
   Google Scholar